MORRIS PLAINS, N.J., April 10, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that four presentations will be given at the 2008 Annual Meeting of the American Association for Cancer Research, scheduled for April 12 - 16, 2007, in San Diego, California. The schedule and meeting places for the poster sessions, together with the abstract and poster board numbers are listed below:
